Corrigendum to "Immune responses elicited by bacterial minicells capable of simultaneous DNA and protein antigen delivery" [Vaccine 2006;24(33-34):6009-6017] (DOI:10.1016/j.vaccine.2006.04.063);Immune responses elicited by bacterial minicells capable of simultaneous DNA and protein antigen delivery

Vaccine

Volumn 24, Issue 33-34, 2006, Pages 6009-6017

  Giacalone, Matthew J ^a   Sabbadini, Roger A ^a,b   Chambers, Amy L ^a   Pillai, Sabitha ^a   McGuire, Kathleen L ^a,b  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Immune response; Minicells; Mucosal immunity; Vaccine

Indexed keywords

BACTERIAL VACCINE; DNA VACCINE; DRUG CARRIER; PLASMID DNA;

ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GENE TARGETING; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 33746055692     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.04.072     Document Type: Erratum

References (44)

1. Dennis C. The bugs of war. Nature 411 (2001) 232-235
2. Stephenson J. Experts focus on infective agents of bioterrorism. Jama 287 (2002) 575-576
3. Djavani M., Yin C., Xia L., Lukashevich I.S., Pauza C.D., and Salvato M.S. Murine immune responses to mucosally delivered Salmonella expressing Lassa fever virus nucleoprotein. Vaccine 18 (2000) 1543-1554
4. Brown W.R. Enteric immunization: promises and challenges. Digest Dis 14 (1996) 192-200
5. Fooks A.R. Development of oral vaccines for human use. Curr Opin Mol Ther 2 (2000) 80-86
6. Davison J. Genetic exchange between bacteria in the environment. Plasmid 42 (1999) 73-91
7. Davison J. Towards safer vectors for the field release of recombinant bacteria. Environ Biosafety Res 1 (2002) 9-18
8. Dzidic S., and Bedekovic V. Horizontal gene transfer-emerging multidrug resistance in hospital bacteria. Acta Pharmacol Sin 24 (2003) 519-526
9. Donsante A., Vogler C., Muzyczka N., Crawford J.M., Barker J., Flotte T., et al. Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors. Gene Ther 8 (2001) 1343-1346
10. Holmgren J., Czerkinsky C., Eriksson K., and Mharandi A. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. Vaccine 21 Suppl 2 (2003) S89-S95
11. Khachatourians G.G., and Berezowsky. Expression of recombinant DNA functional products in Escherichia coli anucleate minicells. Biotech Adv 4 (1986) 75-93
12. Clark J.E., and Curtiss R.C. Analysis of recombinant DNA using Escherichia coli minicells. Methods Enzymol 101 (1983) 347-362
13. Rashtchian A., Brown S.W., Reichler J., and Levy S.B. Plasmid segregation into minicells is associated with membrane attachment and independent of plasmid replication. J Bacteriol 165 (1986) 82-87
14. Crooks J.H., Ullman M., Zoller M., and Levy S.B. Transcription of plasma DNA in Escherichia coli minicells. Plasmid 10 (1983) 66-72
15. Hollenberg C.P., Kustermann-Kuhn B., and Royer H.D. Synthesis of high molecular weight polypeptides in Escherichia coli minicells directed by cloned Saccharomyces cerevisiae 2-micron DNA. Gene 1 (1976) 33-47
16. Ponta H., Reeve J.N., Pfennig-Yeh M., Hirsch-Kauffmann M., Schweiger M., and Herlich P. Productive T7 infection of Escherichia coli F+ cells and anucleate minicells. Nature 269 (1977) 440-442
17. Shepherd N., Dennis P., and Bremer H. Cytoplasmic RNA polymerase in Escherichia coli. J Bacteriol 183 (2001) 2527-2534
18. Akira S., and Takeda K. Functions of toll-like receptors: lessons from KO mice. C R Biol 327 (2004) 581-589
19. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu Rev Immunol 21 (2003) 335-376
20. Takeda K. Toll-like receptor. Nihon Rinsho Meneki Gakkai Kaishi 28 (2005) 309-317
21. Takeda K., and Akira S. Toll-like receptors in innate immunity. Int Immunol 17 (2005) 1-14
22. van Duin D., Medzhitov R., and Shaw A.C. Triggering TLR signaling in vaccination. Trends Immunol (2005)
23. Otterbein L.E., May A., and Chin B.Y. Carbon monoxide increases macrophage bacterial clearance through Toll-like receptor (TLR)4 expression. Cell Mol Biol (Noisy-le-grand) 51 (2005) 433-440
24. Zeller R.W., Weldon D.S., Pellatiro M.A., and Cone A.C. Optimized green fluorescent protein variants provide improved single cell resolution of transgene expression in ascidian embryos. Dev Dyn 235 2 (2005) 456-467
25. Giacalone M.J., Gentile A.M., Lovitt B.T., Berkley N.L., Gunderson C.W., and Surber M.W. Toxic protein expression in E. coli using a new tightly regulated and tunable promoter system. Biotechniques 40 (2006) 355-364
26. Frazer A.C., and Curtiss III R. Production, properties and utility of bacterial minicells. Curr Top Microbiol Immunol 69 (1975) 1-84
27. Frazer A.C., and Curtiss III R. Derepression of anthranilate synthase in purified minicells of Escherichia coli containing the Col-trp plasmid. J Bacteriol 115 (1973) 615-622
28. Bastos K.R., de Deus Vieira de Moraes L., Zago C.A., Marinho C.R., Russo M., Alvarez J.M., et al. Analysis of the activation profile of dendritic cells derived from the bone marrow of interleukin-12/interleukin-23-deficient mice. Immunology 114 (2005) 499-506
29. Grillot-Courvalin C. Wild-type intracellular bacteria deliver DNA into mammalian cells. Cell Microbiol 4 (2002) 177-186
30. Fennelly G.J., Khan S.A., Abadi M.A., Wild T.F., and Bloom B.R. Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector. J Immunol 162 (1999) 1603-1610
31. Molina V., and Shoenfeld Y. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 38 (2005) 235-245
32. Schattner A. Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 23 (2005) 3876-3886
33. Doria-Rose N.A., and Haigwood N.L. DNA vaccine strategies: candidates for immune modulation and immunization regimens. Methods 31 (2003) 207-216
34. Eo S.K., Gierynska M., Kamar A.A., and Rouse B.T. Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules. J Immunol 166 (2001) 5473-5479
35. Moingeon P. Strategies for designing vaccines eliciting Th1 responses in humans. J Biotechnol 98 (2002) 189-198
36. Ramshaw I.A., and Ramsay A.J. The prime-boost strategy: exciting prospects for improved vaccination. Immunol Today 21 (2000) 163-165
37. Viret J.F., Favre D., Wegmuller B., Herzog C., Que J.U., Cryz Jr. S.J., et al. Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria. Infect Immun 67 (1999) 3680-3685
38. Novak M.J., Moldoveanu Z., Huang W.Q., Jackson C.A., Palmer M.T., McPherson S.A., et al. Intramuscular immunization with poliovirus replicons primes for a humoral and cellular immune response to soluble antigen. Viral Immunol 16 (2003) 169-182
39. Vindurampulle C.J., and Attridge S.R. Impact of vector priming on the immunogenicity of recombinant Salmonella vaccines. Infect Immun 71 (2003) 287-297
40. Metzger W.G., Mansouri E., Kronawitter M., Diescher S., Soerensen M., Hurwitz R., et al. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine 22 (2004) 2273-2277
41. Cheroutre H. Starting at the beginning: new perspectives on the biology of mucosal T cells. Annu Rev Immunol 22 (2004) 217-246
42. Cheroutre H., and Madakamutil L. Acquired and natural memory T cells join forces at the mucosal front line. Nat Rev Immunol 4 (2004) 290-300
43. Cheroutre H., and Madakamutil L. Mucosal effector memory T cells: the other side of the coin. Cell Mol Life Sci 62 (2005) 2853-2866
44. Takahashi I., Marinaro M., Kiyono H., Jackson R.J., Nakagawa I., Fujihashi K., et al. Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J Infect Dis 173 (1996) 627-635